With a boost from new funding, faculty are investigating the underlying causes of post-treatment Lyme disease syndrome and working on a better diagnostic test.
Following a recent outbreak in India, two Tufts University experts explain how Nipah virus moves from animals to people—and how smarter prevention can reduce future risk.
In a step toward disease-modifying therapy, Tufts researchers and collaborators have pioneered nanoparticles that target damaged cartilage and adapt to disease severity.